Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.
A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by researchers at the Fraunhofer Translational Center for Regenerative Therapies.
Increasing iPSC Numbers through Systematic Culture Process Optimization in Bioreactors with Live Q&A
Human induced pluripotent stem cells (hiPSCs) are a powerful tool for innovative approaches, such as drug discovery, in vitro disease modelling, or regenerative therapies. However, such procedures ...
Milestone "will shift the conversation about what plant cell culture can realistically achieve,” says California Cultured.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results